Department of Psychology, American University, 4400 Massachusetts Ave NW, Washington, DC, 20016, USA.
Department of Clinical Research, Division of Clinical Epidemiology, University Hospital Basel, Totengässlein 3, 4051, Basel, Switzerland.
BMC Health Serv Res. 2023 Aug 4;23(1):827. doi: 10.1186/s12913-023-09856-z.
Low- and middle-income countries (LMICs) have the highest socio-economic burden of mental health disorders, yet the fewest resources for treatment. Recently, many intervention strategies, including the use of brief, scalable interventions, have emerged as ways of reducing the mental health treatment gap in LMICs. But how do decision makers prioritize and optimize the allocation of limited resources? One approach is through the evaluation of delivery costs alongside intervention effectiveness of various types of interventions. Here, we evaluate the cost-effectiveness of Shamiri, a group- and school-based intervention for adolescent depression and anxiety that is delivered by lay providers and that teaches growth mindset, gratitude, and value affirmation.
We estimated the cost-effectiveness of Shamiri using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) guidelines for economic evaluations. Changes in depression and anxiety were estimated using the Patient Health Questionnaire (PHQ-8) and Generalized Anxiety Disorder questionnaire (GAD-7) at treatment termination and 7-month follow-up using two definitions of treatment benefit. Cost-effectiveness metrics included effectiveness-cost ratios and cost per number needed to treat.
Base case cost assumptions estimated that delivering Shamiri cost $15.17 (in 2021 U.S. dollars) per student. A sensitivity analysis, which varied cost and clinical change definitions, estimated it cost between $48.28 and $172.72 to help 1 student in Shamiri, relative to the control, achieve reliable and clinically significant change in depression and anxiety by 7-month follow-up.
Shamiri appears to be a low-cost intervention that can produce clinically meaningful reductions in depression and anxiety. Lay providers can deliver effective treatment for a fraction of the training time that is required to become a licensed mental health provider (10 days vs. multiple years), which is a strength from an economic perspective. Additionally, Shamiri produced reliable and clinically significant reductions in depression and anxiety after only four weekly sessions instead of the traditional 12-16 weekly sessions necessary for gold-standard cognitive behavioral therapy. The school setting, group format, and economic context of a LMIC influenced the cost per student; however, broader conclusions about the cost-effectiveness of Shamiri have yet to be determined due to limited economic evaluations of mental health programs in LMICs.
This study was registered prior to participant enrollment in the Pan-African Clinical Trials Registry (PACTR201906525818462), registered 20 Jun 2019, https://pactr.samrc.ac.za/Search.aspx .
中低收入国家(LMICs)承担着心理健康障碍的最高社会经济负担,但治疗资源却最少。最近,许多干预策略,包括使用简短、可扩展的干预措施,已成为缩小 LMICs 心理健康治疗差距的方法。但是,决策者如何优先考虑并优化有限资源的分配呢?一种方法是通过评估各种类型干预措施的交付成本及其对干预效果的影响。在这里,我们评估了 Shamiri 的成本效益,Shamiri 是一种针对青少年抑郁和焦虑的团体和学校为基础的干预措施,由非专业人员提供,教授成长心态、感恩和价值肯定。
我们使用健康经济评估报告标准(CHEERS)指南来评估 Shamiri 的成本效益。使用患者健康问卷(PHQ-8)和广泛性焦虑症问卷(GAD-7)在治疗结束和 7 个月随访时评估抑郁和焦虑的变化,使用两种治疗效益定义。成本效益指标包括效果成本比和每例治疗所需成本。
基本案例成本假设估计每个学生的 Shamiri 交付成本为 15.17 美元(2021 年美元)。一项敏感性分析,改变成本和临床变化的定义,估计每个学生在 Shamiri 中的治疗成本在 48.28 美元至 172.72 美元之间,与对照组相比,通过 7 个月的随访,Shamiri 可以帮助 1 名学生在抑郁和焦虑方面实现可靠且具有临床意义的变化。
Shamiri 似乎是一种低成本的干预措施,可以显著降低抑郁和焦虑。非专业人员可以在成为有执照的心理健康提供者所需的培训时间(10 天与多年)的一小部分时间内提供有效的治疗,从经济角度来看,这是一个优势。此外,Shamiri 在仅仅进行了四周的每周一次的治疗后,就产生了可靠且具有临床意义的抑郁和焦虑缓解,而传统的认知行为疗法需要 12-16 周的每周一次的治疗。LMIC 中的学校环境、团体形式和经济背景影响了每名学生的成本;然而,由于对 LMIC 中的心理健康计划进行的经济评估有限,Shamiri 的成本效益的更广泛结论尚未确定。
本研究在参与者入组前在泛非临床试验注册中心(PACTR201906525818462)进行了注册,注册日期为 2019 年 6 月 20 日,网址为 https://pactr.samrc.ac.za/Search.aspx。